Method and antisense composition for selective inhibition of HIV infection in hematopoietic cells

Details for Australian Patent Application No. 2004285494 (hide)

Owner AVI BioPharma, Inc.

Inventors Iversen, Patrick L.; Mourich, Dan V.

Agent FB Rice

Pub. Number AU-A-2004285494

PCT Pub. Number WO2005/041874

Priority 10/971,959 21.10.04 US; 60/514,064 23.10.03 US

Filing date 22 October 2004

Wipo publication date 12 May 2005

International Classifications

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61K 31/675 (2006.01) - having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate

Event Publications

18 May 2006 PCT application entered the National Phase

  PCT publication WO2005/041874 Priority application(s): WO2005/041874

16 August 2007 Amendment Made

  The nature of the amendment is: Add co-inventor Bestwick, Richard K.

26 May 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004285497-Dopamine-, norepinephrineand serotonintransporterselective heterocyclic compounds and their therapeutic applications

2004285488-Continuous water ride